← Back to headlines
ANI Pharmaceuticals Targets $1B+ Sales in 2026, Pivots to Rare Disease Growth at Raymond James Conf.
ANI Pharmaceuticals outlined its strategic vision at the Raymond James Conference, aiming for over $1 billion in sales by 2026, with a key focus on expanding its presence in the rare disease market.
3 Mar, 13:42 — 3 Mar, 13:42
ℹOnly 1 source covers this story
